Archives

by in
Entry Author Date Location
Cardio Study Gives Life To Armetheon’s Blood-Thinning Drug 02/09/15 San Francisco
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
FDA’s Hamburg Stepping Down With Biopharma Turnaround as Her Legacy 02/05/15 National
Cancer Drug Developer G1 Therapeutics Closes $33M Series B Round 02/05/15 Raleigh Durham
Report: Troubled Salix Emerges as Valeant’s Latest Takeover Target 02/03/15 Raleigh Durham
Guardant Grabs $50M to Expand Cancer Blood Test 02/03/15 San Francisco
Texas Roundup: Volusion, SeatSmart, Xenex, Decisio, BioHouston, AveXis 02/02/15 Texas
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More 01/30/15 Boston
West Coast Biotech Roundup: Qualcomm, Google X, Mapp, Onyx, & More 01/29/15 San Francisco
Investors Line up For Westphal as Muscle Cramp Startup Upsizes IPO 01/28/15 Boston
FDA Nod in Hand, Health IT Software Maker Decisio Hits the Market 01/27/15 Texas
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex 01/16/15 National
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
Titan Spine Eyes Bigger Slice of Tricky Spinal Fusion Market 01/13/15 Wisconsin
NPS Pharma’s Long Road Ends With a $5.2B Shire Buyout 01/11/15 New York
Don’t Get Comfortable: 5 Biopharma Flashpoints to Consider in 2015 01/06/15 National
Hepatitis C Commercial Game Theory 01/01/15 National
Enanta Pockets $75M As AbbVie, Gilead Hep C Battle Begins 12/19/14 Boston
Auspex Shares Soar on Late-Stage Results from Huntington’s Study 12/16/14 San Diego
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
Roundup: Delphinius Medical Technologies, Fontinalis, U-M, Detroit Labs 12/12/14 Detroit
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Bluebird 4 For 4 As Gene Therapy Helps More Blood Disease Patients 12/08/14 Boston
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
Prescription Drug Pricing: The Fine Line Between Value and Greed 12/02/14 Boston
Exact Sciences Gets Medicare Reimbursement, Pursues Private Insurers 11/25/14 Wisconsin
Spot On Sciences Aims to Take Pain, Hassle Out of Blood Tests 11/25/14 Texas
BioMarin Gambles $840M on Prosensa’s Duchenne Drug 11/24/14 San Francisco
With Gilead’s $125M Purchase, FDA Voucher Program Gains Momentum 11/19/14 San Francisco
CF Foundation Cashes Out on Kalydeco in $3.3B Sale to Royalty Pharma 11/19/14 Boston
Page 3 of 44 « previous page · next page »